Jason Yang

Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.

Jian Li, Shirong Cai, Yongjian Zhou, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study.

Y. Bai, Jufeng Wang, Shegan Gao, 2024, Nature medicine.